ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

Diet, Nutrition Committee To Rate Suggested Projects

January 9, 1976

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981